Home / Industry / Medical Devices / Biosensors for Point-of-Care Diagnostics Market

Biosensors for Point-of-Care Diagnostics Market

Biosensors for Point-of-Care Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: Feb 2026 | Format: | No. of Pages: 210

Industry: Medical Devices | Author Name: Sayali

Request Customisation / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Biosensors for Point-of-Care Diagnostics Market

The market is expected to surpass the valuation of US$27.6 Bn by the end of 2033.

Between 2026 and 2033, the market for biosensors for point-of-care diagnostics is poised to witness a CAGR of 4%.

Product-wise, molecular diagnostic biosensors are likely to gain prominence over others. Whereas by application, glucose monitoring will be the leading market segment.

Asia Pacific is expected to dominate the biosensors for the point-of-care diagnostics market.

Danaher Corporation, Bio-Rad Laboratories Inc., Zimmer & Peacock AS, Medtronic plc, Koninklijke Philips N.V., and Abbott Laboratories are some of the major companies steering the competitive landscape of the global biosensors for point-of-care diagnostics market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services